Position in LQDA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,336,222
-$842,718 QoQ
Shares Held
35,406
-44.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GSA CAPITAL PARTNERS LLP holds $10,107,066 across 16 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRWD |
Ironwood Pharmaceuticals Inc
|
654,445 | $2,297,101 | |
| 2 | LQDA |
Liquidia Corp
This page
|
35,406 | $1,336,222 | |
| 3 | VTRS |
Viatris Inc
|
89,952 | $1,215,251 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
6,688 | $881,077 | |
| 5 | RGC |
Regencell Bioscience Holdings Ltd
|
31,569 | $802,799 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
101,438 | $588,340 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
10,556 | $545,639 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
11,257 | $542,024 |
All Filings in LQDA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,336,222 | 35,406 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,178,940 | 63,176 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $878,241 | 38,621 | Shares | Sole | 2025-11-07 | |
| 2024-12-31 | $884,363 | 75,201 | Shares | Sole | 2025-02-07 | |
| 2023-06-30 | $527,049 | 67,140 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $135,311 | 19,582 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $112,514 | 25,806 | Shares | Sole | 2022-08-09 | |
| 2021-03-31 | $242,936 | 90,311 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||